MYocardial DOmmages Related to COVID-19

Centre Hospitalier Universitaire Dijon273 enrolled

Overview

Myocardial injury, as assessed by elevation of cardiac troponins (Tnc), is frequent among patients with COVID-19. Although rare autopsy cases reported COVID-19 related myocardial inflammation, the origin of Tnc elevation is unknown to date. Several cardiac causes, such as myocarditis, non-ischemic myocardial injury (NIMI), or myocardial infarction (MI) may lead to Tnc kinetic. Our work will test the hypothesis that during SARS-Cov2 infection, the elevation of cardiac biomarkers could be linked to the occurrence of myocarditis.

Study Type

OBSERVATIONAL

Enrollment

273

Conditions

Covid19 Non Ischemic Myocardial Injury Myocardial Infarction Myocarditis Troponin Elevation

Interventions

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * COVID-19 positive patient hospitalized \< 72 h after symptoms onset with troponin assessement. Exclusion Criteria: * patients hospitalized \> 72h after symptom onset

Outcomes

Primary Outcomes

characterize the myocardial damage associated with CoV-2 SARS infection

Myocardtitis diagnosis in patients COVID+ and troponin+

Time frame: Through study completion, an average of 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.